5//SEC Filing
Finnegan Paul 5
Accession 0001078782-13-000481
CIK 0001360214other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 8:28 PM ET
Size
8.1 KB
Accession
0001078782-13-000481
Insider Transaction Report
Form 5
Finnegan Paul
Director
Transactions
- Award
Option (Right to Buy)
2012-02-28+125,000→ 150,000 totalExercise: $3.20Exp: 2017-01-22→ Common Stock (125,000 underlying) - Award
Option (Right to Buy)
2012-04-01+25,000→ 150,000 totalExercise: $4.50Exp: 2017-03-31→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The stock option was granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan") and vests in three equal annual installments beginning on January 6, 2013. The option was approved by the Issuer's Board of Directors on January 23, 2012, subject to shareholder approval of an amendment to the Plan, which was obtained on February 28, 2012.
- [F2]The stock option was granted under the Plan and vests in four equal quarterly installments beginning on June 30, 2012.
Documents
Issuer
Imprimis Pharmaceuticals, Inc.
CIK 0001360214
Entity typeother
Related Parties
1- filerCIK 0001433553
Filing Metadata
- Form type
- 5
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 8:28 PM ET
- Size
- 8.1 KB